Treace Medical Concepts Inc
Open
4.14 10.11
Overview
Share price change
24h
Min
3.84
Max
4.25
Income | -8.6M -18M |
|---|---|
Sales | -15M 47M |
EPS | -0.12 |
Profit margin | -38.055 |
Employees | 450 |
EBITDA | -11M -16M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +14.8% upside |
Next Earnings | 6 sie 2026 |
|---|
Market Cap | 109M 228M |
|---|---|
Previous open | -5.97 |
Previous close | 4.14 |
Treace Medical Concepts Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.